Short-Term <span style="font-variant: small-caps">l</span>-arginine Treatment Mitigates Early Damage of Dermal Collagen Induced by Diabetes

Changes in the structural properties of the skin due to collagen alterations are an important factor in diabetic skin complications. Using a combination of photonic methods as an optic diagnostic tool, we investigated the structural alteration in rat dermal collagen I in diabetes, and after short-te...

全面介紹

書目詳細資料
發表在:Bioengineering
Main Authors: Irena Miler, Mihailo D. Rabasovic, Sonja Askrabic, Andreas Stylianou, Bato Korac, Aleksandra Korac
格式: Article
語言:英语
出版: MDPI AG 2024-04-01
主題:
在線閱讀:https://www.mdpi.com/2306-5354/11/4/407
實物特徵
總結:Changes in the structural properties of the skin due to collagen alterations are an important factor in diabetic skin complications. Using a combination of photonic methods as an optic diagnostic tool, we investigated the structural alteration in rat dermal collagen I in diabetes, and after short-term <span style="font-variant: small-caps;">l</span>-arginine treatment. The multiplex approach shows that in the early phase of diabetes, collagen fibers are partially damaged, resulting in the heterogeneity of fibers, e.g., “patchy patterns” of highly ordered/disordered fibers, while <span style="font-variant: small-caps;">l</span>-arginine treatment counteracts to some extent the conformational changes in collagen-induced by diabetes and mitigates the damage. Raman spectroscopy shows intense collagen conformational changes via amides I and II in diabetes, suggesting that diabetes-induced structural changes in collagen originate predominantly from individual collagen molecules rather than supramolecular structures. There is a clear increase in the amounts of newly synthesized proline and hydroxyproline after treatment with <span style="font-variant: small-caps;">l</span>-arginine, reflecting the changed collagen content. This suggests that it might be useful for treating and stopping collagen damage early on in diabetic skin. Our results demonstrate that <span style="font-variant: small-caps;">l</span>-arginine attenuates the early collagen I alteration caused by diabetes and that it could be used to treat and prevent collagen damage in diabetic skin at a very early stage.
ISSN:2306-5354